Paper Details
Call For Papers
Volume 5, Issue 7
Frequency: 12 Issue per year
Paper Submission: Throughout the Month
Acceptance Notification: Within 2 days
Areas Covered: Multidisciplinary
Accepted Language: Multiple Languages
Journal Type: Online (e-Journal)
Sample Certificate
Announcement
Publish books with ISBN Number
- Edited Book
- Text Book
- Ph.D Thesis
- Conference Proceedings
ISSN Number:
2582-8568
Journal DOI No:
03.2021-11278686
Title:
JUXTAPOSITION EFFECT OF INDIAN PHARMACEUTICAL STOCK PRICES IN POST COVID-19 ERA
Authors:
Cite this Article:
,
JUXTAPOSITION EFFECT OF INDIAN PHARMACEUTICAL STOCK PRICES IN POST COVID-19 ERA, International Research Journal of Humanities and Interdisciplinary Studies (www.irjhis.com), ISSN : 2582-8568, Volume: 2, Issue: 7, Year: July 2021, Page No : 33-41,
Available at : http://irjhis.com/paper/IRJHIS2107007.pdf
Abstract:
When modern medicines are used widely for healing instead of India’s medical practices, a shield that had been ignored by Indian investors and media is resurging from the ashes; the Indian Pharmaceutical Companies. The stock prices of the Indian Pharma companies were dipped significantly over the last four years, and when the demand for a cure is in the limelight like never before. The Indian Pharma companies listed in BSE and NSE had their share of the favourable tide. Apart from the development, repurposing the existing drugs also found quite promising during these trial-and-error scenarios supportive to the Indian pharma companies. Nevertheless, as a nation, is India doing what it could do to benefit from this opportunity in disguise? The author is trying to portray the realities of Atmanirbhar Bharat with a pinch of reality about the associated Pharma companies.
Keywords:
Indian Pharmaceutical Companies, API, Indian Investors, Covid-19
Publication Details:
Published Paper ID: IRJHIS2107007
Registration ID: 20269
Published In: Volume: 2, Issue: 7, Year: July 2021
Page No: 33-41
ISSN Number: 2582-8568
Download Full Paper: Click Here
Article Preview:
